A Study of Apalutamide Combined With GnRH Agonist in Participants With Androgen Receptor Positive Salivary Gland Carcinoma
A Study of Apalutamide Combined With GnRH Agonist in Participants With Androgen Receptor Positive Salivary Gland Carcinoma
Active, not recruiting · NCT04325828 · Registry updated 2026-09-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Apalutamide Combined With GnRH Agonist in Participants With Androgen Receptor Positive Salivary Gland Carcinoma | Head and Neck Neoplasms, Mouth Neoplasms, Neoplasms by Site, Stomatognathic Diseases, mouth disorder, neoplasm, salivary gland cancer, salivary gland disorder | Active, not recruiting | Phase 2 | 2026-09-25 | NCT04325828 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Janssen Pharmaceutical K.K. | 3 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Aichi Cancer Center Hospital | Nagoya | Japan | 4 |
| Hokkaido University Hospital | Sapporo | Japan | 34 |
| Kansai Medical University Hospital | Hirakata | Japan | 10 |
| National Cancer Center Hospital | Chūōku | Japan | 7 |
| National Hospital Organization Kyushu Medical Center | Fukuoka | Japan | 8 |
| National Hospital Organization Shikoku Cancer Center | Matsuyama | Japan | 1 |
| Niigata University Medical And Dental Hospital | Niigata | Japan | 4 |